Holen Sie sich die Stockscreener-App
15.29
0.13%
0.02
Vorhandelsmarkt:
15.40
0.11
+0.72%
Schlusskurs vom Vortag:
$15.27
Offen:
$15.27
24-Stunden-Volumen:
466.79K
Relative Volume:
0.56
Marktkapitalisierung:
$454.85M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-22.16
EPS:
-0.69
Netto-Cashflow:
$-9.08M
1W Leistung:
+11.77%
1M Leistung:
+12.92%
6M Leistung:
+29.58%
1J Leistung:
-0.97%
1-Tages-Spanne:
$14.83
$15.79
1-Wochen-Bereich:
$13.50
$15.79
52-Wochen-Spanne:
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
15.29 | 454.26M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
127.04 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.77 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.83 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
ClearPoint Neuro Restructures IRRAS Subsidiary Under Debt Agreement - TipRanks
ClearPoint Neuro enters consent agreement related to IRRAS AB reorganization - Investing.com Nigeria
ClearPoint Neuro Signs Consent to Note Purchase Agreement With Oberland Capital - TradingView — Track All Markets
Technical Reactions to CLPT Trends in Macro Strategies - Stock Traders Daily
ClearPoint Neuro enters consent agreement related to IRRAS AB reorganization By Investing.com - Investing.com Nigeria
Published on: 2025-12-27 12:00:42 - bollywoodhelpline.com
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a Potential 100% Upside in the Healthcare Sector - DirectorsTalk Interviews
What Creates a Long-Term Growth Opportunity for ClearPoint Neuro (CLPT)? - Insider Monkey
(CLPT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
What analysts say about ClearPoint Neuro Inc stockEquity Performance Review & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet? - 富途牛牛
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Analyst Calls: How strong is AMTD IDEA Group Depositary Receipt stock balance sheetJuly 2025 Decliners & AI Forecast Swing Trade Picks - moha.gov.vn
retail investors who own 51% along with institutions invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) saw increase in their holdings value last week - simplywall.st
Is ClearPoint Neuro Inc. stock supported by innovation pipelinePortfolio Performance Summary & Daily Chart Pattern Signal Reports - Улправда
How ClearPoint Neuro Inc. stock benefits from tech adoptionWeekly Trade Report & Fast Gain Stock Tips - Улправда
How ClearPoint Neuro Inc. stock valuations compare to rivalsJuly 2025 Recap & Fast Moving Stock Trade Plans - Улправда
Behavioral Patterns of CLPT and Institutional Flows - Stock Traders Daily
ClearPoint Neuro Announces Merger with IRRAS Holdings - MSN
Latham & Watkins Advises IRRAS on Acquisition by ClearPoint Neuro - Latham & Watkins LLP
Trend Review: Will ClearPoint Neuro Inc. stock outperform Nasdaq index2025 Market WrapUp & Weekly Setup with ROI Potential - moha.gov.vn
Geode Capital Management LLC Buys 323,429 Shares of ClearPoint Neuro, Inc. $CLPT - MarketBeat
Here’s What Boosted ClearPoint Neuro (CLPT) in Q3 - Insider Monkey
Can ClearPoint Neuro Inc. stock withstand economic slowdownMarket Sentiment Review & Free Safe Entry Trade Signal Reports - Newser
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
Is ClearPoint Neuro Inc. stock positioned well for digital economyPortfolio Risk Summary & Daily Entry Point Alerts - Newser
ClearPoint Neuro (CLPT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will ClearPoint Neuro Inc. stock maintain dividend yieldJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - Newser
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Bristol-Myers Squibb (BMY) - The Globe and Mail
[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and ClearPoint Neuro (CLPT) - The Globe and Mail
What drives ClearPoint Neuro Inc stock priceMarket Sentiment Report & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
ClearPoint Neuro Completes Acquisition of IRRAS Holdings - MSN
ClearPoint Neuro completes acquisition of IRRAS Holdings - Investing.com India
ClearPoint Neuro completes acquisition of IRRAS Holdings By Investing.com - Investing.com Australia
How (CLPT) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
[8-K] ClearPoint Neuro, Inc. Reports Material Event | CLPT SEC FilingForm 8-K - Stock Titan
ClearPoint Neuro Completes Acquisition of IRRAS - ACCESS Newswire
ClearPoint (Nasdaq: CLPT) closes IRRAS deal, adding IRRAflow and 50+ customers - Stock Titan
Is ClearPoint Neuro Inc. stock a top pick in earnings seasonShare Buyback & Real-Time Volume Spike Alerts - newser.com
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):